(Total Views: 508)
Posted On: 10/06/2025 5:50:00 PM
Post# of 157810
I feel the silence over the Summer and the massive cuts research are connected.
The cuts to the National Cancer Institute ($1 billion), National Heart, Lung and Blood Institute ($575 million), and the National Institute of Allergy and Infectious Diseases ($838 million). The Centers for Disease Control and Prevention (CDC) cut of $1.2 billion.
This would also explain our trials, we were NOT planning on running our own trials without partners. I still don't think we are alone because there doesn't appear to be any panic about our trials. These are two partnership areas I feel.
Key Takeaways from ESMO Gastrointestinal Cancers Congress 2025
Leronlimab demonstrated partial or complete responses in advanced metastatic colorectal cancer, supporting its potential in solid tumor oncology.
Increased PD-L1 expression in triple-negative breast cancer suggests leronlimab may convert "cold" tumors to "hot," improving immunotherapy response.
The cuts to the National Cancer Institute ($1 billion), National Heart, Lung and Blood Institute ($575 million), and the National Institute of Allergy and Infectious Diseases ($838 million). The Centers for Disease Control and Prevention (CDC) cut of $1.2 billion.
This would also explain our trials, we were NOT planning on running our own trials without partners. I still don't think we are alone because there doesn't appear to be any panic about our trials. These are two partnership areas I feel.
Key Takeaways from ESMO Gastrointestinal Cancers Congress 2025
Leronlimab demonstrated partial or complete responses in advanced metastatic colorectal cancer, supporting its potential in solid tumor oncology.
Increased PD-L1 expression in triple-negative breast cancer suggests leronlimab may convert "cold" tumors to "hot," improving immunotherapy response.
(4)
(0)
